Lv11
40 积分 2022-01-12 加入
Linking tumour angiogenesis and tumour immunity
6小时前
待确认
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
13天前
已完结
Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study
1个月前
已完结
Acute myocarditis during carboplatin and pemetrexed chemotherapy for lung adenocarcinoma
1个月前
已完结
Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small-cell lung cancer: results of a phase I/II trial
1个月前
已完结
Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab
1个月前
已完结
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
2个月前
已完结
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
2个月前
已完结
Emerging Options and Future Strategies in Immunotherapy for Advanced Lung Squamous Cell Carcinoma
2个月前
已完结
皖公网安备34019202002308
